Ishihara Sangyo Kaisha (4028) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
20 Nov, 2025Executive summary
Net sales for the three months ended June 30, 2025, rose 13.2% year-over-year to ¥42,561 million, with operating profit surging 191.4% to ¥5,206 million and ordinary profit up 49.7% to ¥6,190 million.
Profit attributable to owners of parent increased 64.8% year-over-year to ¥4,737 million, and basic earnings per share rose to ¥123.82 from ¥75.24.
Financial highlights
Gross profit increased from ¥8,892 million to ¥12,316 million year-over-year, while selling, general and administrative expenses remained stable.
Total assets grew to ¥237,330 million as of June 30, 2025, up from ¥225,097 million at the previous fiscal year-end.
Net assets increased to ¥115,594 million, with an equity-to-asset ratio of 48.6%.
Comprehensive income for the quarter was ¥4,307 million, up 9.7% year-over-year.
Outlook and guidance
Full-year net sales are forecast at ¥147,000 million (up 1.2% year-over-year), with operating profit projected at ¥15,000 million (up 43.1%) and profit attributable to owners of parent at ¥9,200 million (up 9.4%).
Basic earnings per share for the full year is forecast at ¥240.46.
Dividend forecast for the fiscal year is ¥100 per share.
Latest events from Ishihara Sangyo Kaisha
- Net sales rose 10.4% but net income fell 80.6% due to forex losses and higher costs.4028
Q2 20257 Aug 2026 - Profits and forecasts surged on strong overseas sales, cost controls, and a favorable outlook.4028
Q2 20267 Aug 2026 - FY2025 is forecasted for higher profit and a ¥100 dividend as inorganic chemicals recover.4028
Q4 20257 Aug 2026 - Q1 FY2027 saw steep profit declines and a major impairment loss in Inorganic Chemicals.4028
Q1 20277 Aug 2026 - Profits surged in FY2025, but FY2026/FY2027 is forecast to decline amid higher R&D and normalized demand.4028
Q4 20265 Jun 2026 - Strong profit growth and positive outlook, driven by Organic Chemicals segment.4028
Q3 202613 Feb 2026 - Q1 FY2025 profit dropped over 40% year-over-year despite stable sales; outlook revised down.4028
Q1 202520 Nov 2025 - Sales and operating income rose, but net income fell; dividend forecast increased.4028
Q3 202520 Nov 2025